SOFOSBUVIR (has an active metabolite) | SOFOSBUVIR | ATC J05AX15 ATC J05AX65 ATC J05AP08 ATC J05AP51 ATC J05AP55 ATC J05AP56
ANTIINFECTIVES TREATMENT OF CHRONIC HEPATITIS C (CHC) INFECTION HEPATITIS C VIRUS (HCV) NUCLEOTIDE ANALOG NS5B POLYMERASE INHIBITOR | ORAL | Tmax 1.25 HOUR PPB 63 PERCENT HT 0.4 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | HEPATITIS C VIRUS (HCV) NUCLEOTIDE ANALOG NS5B POLYMERASE | HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE INHIBITOR CHEMBL5375 HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE Q8JXU8 NS5B PROTEIN HEPATITIS C VIRUS ENZYME TRANSFERASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |